A New Twist on Satel­lite Phages

Pic­tures Con­sid­ered #62

by Roberto

In the phage uni­verse, there are many ex­am­ples of so-called satel­lite phages (or satel­lite phage-like el­e­ments) whose prop­a­ga­tion de­pends on helper phages. Out­side the bac­te­r­ial cell these satel­lites look like phages, but nu­cleic acids pack­aged in­side their cap­sids do not have all the genes that would be re­quired for a suc­cess­ful lytic in­fec­tion. What do those genomes en­code in­stead? Many pos­si­bil­i­ties, some­­times a self-repli­cat­ing plas­mid, some­times genes en­cod­ing vir­u­lence fac­tors as Merry de­scribed in this post from 2013.

Fig. 1. P4 life cy­cle. Source

Per­haps the most stud­ied and best un­der­stood of the satel­lite phages is P4 from E. coli whose prop­a­ga­tion in­side a phage cap­sid de­pends on phage P2 (or other sim­i­lar phages). The life cy­cle of the P4 ge­netic el­e­ment is fas­ci­nat­ing as it dis­plays mul­ti­ple and very clever means of prop­a­ga­tion (Fig. 1). Out­side the cell, P4 looks and acts by all cri­te­ria as a phage. It has an icosa­he­dral cap­sid and a tail, and it can in­ject its DNA into its E. coli host. How­ever, its cap­sid and tail pro­teins are all en­coded by the helper phages of the P2 fam­ily. The P4 genome it­self com­pletely lacks the genes en­cod­ing these struc­tural pro­teins. When P4 in­fects an E. coli P2 lyso­gen, it may en­ter ei­ther the lyso­genic or the lytic path­way. For the lytic path­way P4 ab­solutely de­pends on the cap­sid, tail, and ly­sis func­tions of P2. In­ter­est­ingly, since the P4 genome is smaller than that of P2, it makes a smaller cap­sid. To ac­com­plish this, the P4 genome con­tains a gene (sid) whose prod­uct di­rects the cap­sid pro­teins to as­semble into a smaller icosa­he­dron. When P4 in­fects an E. coli that is not a P2 lyso­gen, the P4 genome is ei­ther in­te­grated into the chro­mo­some or es­tab­lishes it­self as an au­tonomously repli­cat­ing mul­ti­copy plas­mid. Glanc­ing at the life cy­cle di­a­gram, one might guess that this type of helper ex­ploita­tion would re­quire that the helper phage be able to es­tab­lish a ly­so­gen state. It is easy to imag­ine that if the helper phage were vir­u­lent, then the helper and satel­lite would have to in­fect the host cell pretty much at the same time. The chances of that hap­pen­ing out in na­ture should be van­ish­ingly low, right? Well... evo­lu­tion seems to have found a way to over­come the odds.

Fig. 2. A col­orized im­age of the Mini­Flayer satel­lite virus latched onto its helper Mind­Flayer. Im­age by Tagide de Car­valho. Source

A re­cent study dis­cov­ered and char­ac­ter­ized a new satel­lite-helper sys­tem, named "Flayer," that in­fects di­verse Strep­to­myces species. Mind­Flayer is the helper and Mini­Flayer the sa­tellite. When plated they yield clear plaques, al­ready in­dica­tive that they might be ex­clu­siv­ely lytic phages. More­over, their genomes do not ap­pear to have any of the genes cha­rac­ter­is­tic of tem­per­ate phages (i.e. able to lyso­g­e­nize). MiniFlayer's genome does con­tain genes cod­ing for cap­sid and tail pro­teins; what makes it a satel­lite seems to be the lack genes cod­ing for en­zymes in­volved in its own DNA repli­ca­tion. If both Mind­Flayer and Mini­Flayer can only prop­a­gate through a lytic life cy­cle, how does Mini­Flayer man­age to in­fect cells that are be­ing in­fected at pre­cisely the same time? The elec­tron mi­cro­graph shows the cha­rac­ter­is­tic ap­pear­ance of these phages (Fig. 2). Amaz­ingly, the ma­jor­ity (80%) of the Mind­Flayer par­ti­cles have a Mini­Flayer at­tached to their tail. Mini­Flayer has a very short tail that likely in­cludes a fiber pro­tein that specif­i­cally binds to MindFlayer's tail. There also ap­pears to be some sort of affin­ity for bind­ing be­tween the cap­sid pro­teins. These pro­tein-pro­tein in­ter­ac­tions lead to the for­ma­tion of "bonded pairs" of helper and satel­lite, thus greatly in­creas­ing the chances of si­mul­ta­ne­ous ad­sorp­tion to the host cell. And since a pic­ture tells one thou­sand words, I'll let you pon­der on the fur­ther phys­i­o­log­i­cal, eco­log­i­cal and, yes, even evo­lu­tion­ary im­pli­ca­tions of this re­mark­able im­age.

 

Do you want to com­ment on this post? We would be happy about it! Please com­ment on Mastodon, or on Bluesky.
 

Other Posts

  • Worms Have Viruses, Too!

    by Manuel Sánchez — When we high­light the im­por­tance of viruses in ecosys­tems, we usu­ally as­sume that all liv­ing things, multi- or uni­cel­lu­lar, can be in­fected by at least one kind of virus. This is not a far-fetched as­sump­tion, but one that un­til now has had to en­dure some no­table ex­cep­tions. Viruses had not…

  • A Los­ing Bat­tle

    by Elio — Rel­a­tively few peo­ple are aware the virus that causes Covid19 has its own name, to wit, SARS-CoV‑2. Out­side the sci­en­tific lit­er­a­ture, this is sel­dom used. Yet, al­most every­one is aware that the AIDS virus is called HIV. But this is ex­cep­tional. The over­whelm­ing num­ber of peo­ple call a virus af­ter the dis­ease...

  • Lit­tle things mat­ter, in both vi­rol­ogy and your PhD

    by Shux­uan Zheng — Blaise Pas­cal said that "Lit­tle things con­sole us be­cause lit­tle things af­flict us." In the time of CO­VID-19, Pascal's words have never been more pre­scient. Viruses – those lit­tle things be­hind the global mi­cro­bi­o­log­i­cal threat – de­mand not only our fear but also our re­spect.

  • Killer Prophage for Hire

    by Merry — Lysogeny is a wide­spread form of sym­bio­sis among bac­te­ria, but hav­ing a res­i­dent prophage is a mixed bless­ing. A prophage can bring ben­e­fits such as re­sis­tance to at­tack by other phages or novel vir­u­lence fac­tors. But along with the ben­e­fits comes a li­a­bil­ity...

  • The Four King­doms of Na­ture

    Pic­tures Con­sid­ered #50 by Christoph — We of­ten talk slop­pily of «al­gae» or «pro­tists» on these pages when we con­sider, rarely enough, uni­cellular eu­kary­otes. For my part, I at­tach lit­tle im­por­tance to bi­o­log­i­cal sys­tem­at­ics or tax­on­omy per se be­cause I'm more in­ter­ested in learn­ing how liv­ing be­ings go about their busi­ness than in sort­ing them into var­i­ous draw­ers. There­fore I mostly con­fine my­self to the names of the...

  • Phage Ther­apy – an Up­date

    by Elio — Has there ever been a more per­plex­ing topic in mi­cro­bi­ol­ogy than phage ther­apy? Well, that of pro­bi­otics comes close. Both have an over 100-year his­tory, both have pro­po­nents as well as de­trac­tors, both have seen ma­jor in­vest­ments in re­search and com­mer­cial­iza­tion.